EMD 273066
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for EMD 273066, covering 2013-10-25 to 2013-10-25. Get the full timeline:
Most recent: Clinical Trial Update: EMD 273066 in Patients With Recurrent EpCAM Positive Ovarian, Prostate, Colorectal or Non-small Cell Lung Cancers When First Given Cyclophosphamide [Phase 1]